Recursion Pharmaceuticals
RXRX
#3699
Rank
A$4.49 B
Marketcap
$11.50
Share price
-3.63%
Change (1 day)
-29.33%
Change (1 year)

EPS for Recursion Pharmaceuticals (RXRX)

EPS in 2023 (TTM): -$2.07

According to Recursion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.22. In 2022 the company made an earnings per share (EPS) of -$2.20 a decrease over its 2021 EPS that were of -$1.87.

EPS history for Recursion Pharmaceuticals from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.07-5.75%
2022-$2.2017.39%
2021-$1.8750.85%
2020-$1.24